Literature DB >> 17599702

Advances in functional magnetic resonance imaging: technology and clinical applications.

Bradford C Dickerson1.   

Abstract

Functional MRI (fMRI) is a valuable method for use by clinical investigators to study task-related brain activation in patients with neurological or neuropsychiatric illness. Despite the relative infancy of the field, the rapid adoption of this functional neuroimaging technology has resulted from, among other factors, its ready availability, its relatively high spatial and temporal resolution, and its safety as a noninvasive imaging tool that enables multiple repeated scans over the course of a longitudinal study, and thus may lend itself well as a measure in clinical drug trials. Investigators have used fMRI to identify abnormal functional brain activity during task performance in a variety of patient populations, including those with neurodegenerative, demyelinating, cerebrovascular, and other neurological disorders that highlight the potential utility of fMRI in both basic and clinical spheres of research. In addition, fMRI studies reveal processes related to neuroplasticity, including compensatory hyperactivation, which may be a universally-occurring, adaptive neural response to insult. Functional MRI is being used to study the modulatory effects of genetic risk factors for neurological disease on brain activation; it is being applied to differential diagnosis, as a predictive biomarker of disease course, and as a means to identify neural correlates of neurotherapeutic interventions. Technological advances are rapidly occurring that should provide new applications for fMRI, including improved spatial resolution, which promises to reveal novel insights into the function of fine-scale neural circuitry of the human brain in health and disease.

Entities:  

Mesh:

Year:  2007        PMID: 17599702     DOI: 10.1016/j.nurt.2007.05.007

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  103 in total

1.  Brain activation during working memory 1 month after mild traumatic brain injury: a functional MRI study.

Authors:  T W McAllister; A J Saykin; L A Flashman; M B Sparling; S C Johnson; S J Guerin; A C Mamourian; J B Weaver; N Yanofsky
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

Review 2.  Neuroimaging and human genetics.

Authors:  Georg Winterer; Ahmad R Hariri; David Goldman; Daniel R Weinberger
Journal:  Int Rev Neurobiol       Date:  2005       Impact factor: 3.230

3.  Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation.

Authors:  Sasha E B Gibbs; Mark D'Esposito
Journal:  Cogn Affect Behav Neurosci       Date:  2005-06       Impact factor: 3.282

4.  High-resolution FMRI at 1.5T using balanced SSFP.

Authors:  Karla L Miller; Stephen M Smith; Peter Jezzard; John M Pauly
Journal:  Magn Reson Med       Date:  2006-01       Impact factor: 4.668

5.  Elaborative verbal encoding and altered anterior parahippocampal activation in adolescents and young adults at genetic risk for schizophrenia using FMRI.

Authors:  Heidi W Thermenos; Larry J Seidman; Russell A Poldrack; Nicole K Peace; Jennifer K Koch; Stephen V Faraone; Ming T Tsuang
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

6.  Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.

Authors:  Rutger Goekoop; Philip Scheltens; Frederik Barkhof; Serge A R B Rombouts
Journal:  Brain       Date:  2005-10-26       Impact factor: 13.501

7.  Functional and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an executive function task and corpus callosum morphometry.

Authors:  Marcel Adam Just; Vladimir L Cherkassky; Timothy A Keller; Rajesh K Kana; Nancy J Minshew
Journal:  Cereb Cortex       Date:  2006-06-13       Impact factor: 5.357

8.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

9.  Training-dependent plasticity in patients with multiple sclerosis.

Authors:  Katrin Morgen; Nadja Kadom; Lumy Sawaki; Alessandro Tessitore; Joan Ohayon; Henry McFarland; Joseph Frank; Roland Martin; Leonardo G Cohen
Journal:  Brain       Date:  2004-09-29       Impact factor: 13.501

Review 10.  A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.

Authors:  Paul Coleman; Howard Federoff; Roger Kurlan
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

View more
  10 in total

Review 1.  Functional network disruption in the degenerative dementias.

Authors:  Michela Pievani; Willem de Haan; Tao Wu; William W Seeley; Giovanni B Frisoni
Journal:  Lancet Neurol       Date:  2011-07-21       Impact factor: 44.182

2.  Potential diagnostic role of diffusion tensor imaging in early-stage osteonecrosis of the femoral head.

Authors:  Hongwei Min; Feng Xu; Rui Gu; Xinzuo Han; Anqing Wang; Kemin Liu
Journal:  Exp Ther Med       Date:  2016-10-11       Impact factor: 2.447

Review 3.  Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies.

Authors:  Bradford C Dickerson; Reisa A Sperling
Journal:  Neuropsychologia       Date:  2007-12-08       Impact factor: 3.139

4.  Plasticity in Early Alzheimer's Disease: An Opportunity for Intervention.

Authors:  Nikki L Hill; Ann M Kolanowski; David J Gill
Journal:  Top Geriatr Rehabil       Date:  2011-10

5.  Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry.

Authors:  Anna Nilsson; Thomas E Fehniger; Lena Gustavsson; Malin Andersson; Kerstin Kenne; György Marko-Varga; Per E Andrén
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

6.  The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study.

Authors:  Dongfeng Wei; Chenlong Lv; Junying Zhang; Dantao Peng; Liangping Hu; Zhanjun Zhang; Yongyan Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 7.  Multisite neuroimaging trials.

Authors:  John Darrell Van Horn; Arthur W Toga
Journal:  Curr Opin Neurol       Date:  2009-08       Impact factor: 5.710

8.  Protein nanoparticles engineered to sense kinase activity in MRI.

Authors:  Mikhail G Shapiro; Jerzy O Szablowski; Robert Langer; Alan Jasanoff
Journal:  J Am Chem Soc       Date:  2009-02-25       Impact factor: 15.419

Review 9.  The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES).

Authors:  C C Gispen-de Wied; M Kritsidima; A J A Elferink
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

Review 10.  A Comprehensive Review of Magnetoencephalography (MEG) Studies for Brain Functionality in Healthy Aging and Alzheimer's Disease (AD).

Authors:  Pravat K Mandal; Anwesha Banerjee; Manjari Tripathi; Ankita Sharma
Journal:  Front Comput Neurosci       Date:  2018-08-23       Impact factor: 2.380

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.